Parkside Financial Bank & Trust Biomarin Pharmaceutical Inc Transaction History

Parkside Financial Bank & Trust

$702 Million
Q3 2024

A detailed history of Parkside Financial Bank & Trust transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 112 shares of BMRN stock, worth $7,462. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112

Previous 298 62.42%

Holding current value

$7,462

Previous $24,000 70.83%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$69.02 - $93.84 $12,837 - $17,454	-186 Reduced 62.42%	112 $7,000
Q2 2024 Aug 05, 2024	SELL	$74.43 - $92.22 $3,944 - $4,887	-53 Reduced 15.1%	298 $24,000
Q1 2024 May 01, 2024	BUY	$83.81 - $99.0 $20,114 - $23,760	240 Added 216.22%	351 $30,000
Q4 2023 Feb 01, 2024	SELL	$76.22 - $98.51 $12,347 - $15,958	-162 Reduced 59.34%	111 $10,000
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $425 - $472	-5 Reduced 1.8%	273 $24,000
Q2 2023 Aug 15, 2023	BUY	$86.68 - $100.3 $15,169 - $17,552	175 Added 169.9%	278 $24,000
Q1 2023 May 04, 2023	SELL	$87.74 - $117.27 $526 - $703	-6 Reduced 5.5%	103 $10,000
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $2,104 - $2,824	26 Added 31.33%	109 $11,000
Q2 2022 Jul 13, 2022	BUY	$71.48 - $86.85 $714 - $868	10 Added 13.7%	83 $7,000
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $2,376 - $2,966	-32 Reduced 30.48%	73 $6,000
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $502 - $640	7 Added 7.14%	105 $10,000
Q3 2021 Oct 29, 2021	BUY	$74.77 - $85.47 $3,813 - $4,358	51 Added 108.51%	98 $7,000
Q2 2021 Aug 06, 2021	BUY	$75.51 - $84.79 $755 - $847	10 Added 27.03%	47 $4,000
Q4 2020 Feb 09, 2021	BUY	$72.61 - $90.2 $2,468 - $3,066	34 Added 1133.33%	37 $3,000
Q3 2020 Nov 06, 2020	SELL	$71.87 - $131.03 $3,306 - $6,027	-46 Reduced 93.88%	3 $0
Q2 2020 Aug 10, 2020	BUY	$79.55 - $124.22 $3,897 - $6,086	49 New	49 $6,000
Q1 2019 May 01, 2019	SELL	$84.2 - $98.62 $2,947 - $3,451	-35 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$80.14 - $106.07 $1,202 - $1,591	-15 Reduced 30.0%	35 $3,000
Q4 2017 Feb 05, 2018	SELL	$80.76 - $95.13 $2,745 - $3,234	-34 Reduced 40.48%	50 $4,000
Q3 2017 Oct 27, 2017	BUY	$80.6 - $94.95 $6,770 - $7,975	84	84 $8,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.

Account

Parkside Financial Bank & Trust Biomarin Pharmaceutical Inc Transaction History